Sex Disparities in Neuro-Ophthalmologic Disorders

References

• Wall M. Idiopathic intracranial hypertension. Neurol Clin 2010;28:593–617
   PubMed Web of Science ®Google Scholar
• Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep 2007;11:62–68
   PubMedGoogle Scholar
• Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155–180
   PubMed Web of Science ®Google Scholar
• Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45:875–857
   PubMed Web of Science ®Google Scholar
• Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 2014;54:1–11
   PubMedGoogle Scholar
• Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010;74:1827–1832
   Google Scholar
• Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology 2009;72:304–309
   PubMed Web of Science ®Google Scholar
• Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127:178–182
   PubMed Web of Science ®Google Scholar
• Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136–143
   PubMedGoogle Scholar
• Fraser JA, Bruce BB, Rucker J, Fraser LA, Atkins EJ, Newman NJ, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci 2010;290:86–89
   PubMed Web of Science ®Google Scholar
• Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002;109:482–485
   PubMed Web of Science ®Google Scholar
• Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988;45:866–872
   PubMed Web of Science ®Google Scholar
• Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology 1984;34:721–729
   PubMed Web of Science ®Google Scholar
• Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (Pseudotumor cerebri): a case-control study. Neurology 1991;41:239–244
   PubMed Web of Science ®Google Scholar
• Soelberg Sorensen P, Gjerris F, Svenstrup B. Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid. Arch Neurol 1986;43:902–906
   Google Scholar
• Reid AC, Thomson JA. Absence of significant endocrine deficiencies in benign intracranial hypertension. J Neurol Neurosurg Psychiatr 1981;44:731–734
   PubMed Web of Science ®Google Scholar
• Donaldson JO, Horak E. Cerebrospinal fluid oestrone in pseudotumour cerebri. J Neurol Neurosurg Psychiatr 1982;45:734–736
   PubMed Web of Science ®Google Scholar
• Toscano V, Sancesario G, Bianchi P, Cicardi C, Casilli D, Giacomini P. Cerebrospinal fluid estrone in pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J Endocrinol Invest 1991;14:81–86
   PubMed Web of Science ®Google Scholar
• Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6:162–170
   PubMed Web of Science ®Google Scholar
• Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791–1798
   PubMed Web of Science ®Google Scholar
• de Bruijn SF, Stam J, Kappelle LJ. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet 1996;348:1623–1635
   PubMedGoogle Scholar
• Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators I. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664–670
   PubMed Web of Science ®Google Scholar
• Coutinho JM, Ferro JM, Canhao P, Barinagarrementeria F, Cantu C, Bousser MG, et al. Cerebral venous and sinus thrombosis in women. Stroke 2009;40:2356–2361
   PubMed Web of Science ®Google Scholar
• deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417–423
   PubMed Web of Science ®Google Scholar
• Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F, Investigators I. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005;36:1927–1932
   Web of Science ®Google Scholar
• Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993;24:1880–1884
   PubMed Web of Science ®Google Scholar
• de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 1998;316:589–592
   PubMedGoogle Scholar
• Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793–1797
   PubMed Web of Science ®Google Scholar
• Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006;107:2766–2773
   PubMed Web of Science ®Google Scholar
• Krayenbuhl HA. Cerebral venous and sinus thrombosis. Clin Neurol 1966;14:1–24
   Google Scholar
• Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010;99:307–314
   PubMed Web of Science ®Google Scholar
• Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-oncology 2012;14:v1–v49
   PubMed Web of Science ®Google Scholar
• Krampla W, Newrkla S, Pfisterer W, Jungwirth S, Fischer P, Leitha T, et al. Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA). Cancer 2004;100:1208–1212
   Google Scholar
• Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821–1828
   PubMed Web of Science ®Google Scholar
• Carroll RS, Glowacka D, Dashner K, Black PM. Progesterone receptor expression in meningiomas. Cancer Res 1993;53:1312–1316
   PubMed Web of Science ®Google Scholar
• Custer B, Longstreth WT, Jr Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 2006;6:152
   PubMed Web of Science ®Google Scholar
• Li X, Zhao J. Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up. Childs Nerv Syst 2009;25:1411–1417
   Google Scholar
• Menon G, Nair S, Sudhir J, Rao BR, Mathew A, Bahuleyan B. Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir (Wien) 2009;151:239–244 (discussion 44)
   PubMed Web of Science ®Google Scholar
• Rao G, Giordano SH, Liu J, McCutcheon IE. The association of breast cancer and meningioma in men and women. Neurosurgery 2009;65:483–489 (discussion 9)
   PubMed Web of Science ®Google Scholar
• Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer 2002;94:1626–1635
   PubMed Web of Science ®Google Scholar
• Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. J Neurosurg 2011;115:1072–1077
   Google Scholar
• Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 2013;118:649–656
   PubMed Web of Science ®Google Scholar
• Cushing H. Meningiomas arising from the tuberculum sellae. Arch Ophthalmol 1929;1:168–205
   Google Scholar
• Weyand RD, Mac CC, Wilson RB. The effect of pregnancy on intracranial meningiomas occurring about the optic chiasm. Surg Clin North Am 1951;31:1225–1233
   Google Scholar
• Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958;21:89–91
   PubMed Web of Science ®Google Scholar
• Michelsen JJ, New PF. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 1969;32:305–307
   PubMed Web of Science ®Google Scholar
• Rand CW, Andler M. Tumors of the brain complicating pregnancy. Arch Neurol Psychiatry 1950;63:1–41
   PubMedGoogle Scholar
• Wan WL, Geller JL, Feldon SE, Sadun AA. Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 1990;97:18–21
   PubMed Web of Science ®Google Scholar
• Moscovici S, Fraifeld S, Cohen JE, Dotan S, Elchalal U, Shoshan Y, et al. Parasellar meningiomas in pregnancy: surgical results and visual outcomes. World Neurosurg 2013; [epub ahead of print] doi: 10.1016/j.wneu.2013.06.019
   Google Scholar
• Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst 1992;84:1346–1349
   Google Scholar
• Cahill DW, Bashirelahi N, Solomon LW, Dalton T, Salcman M, Ducker TB. Estrogen and progesterone receptors in meningiomas. J Neurosurg 1984;60:985–993
   PubMed Web of Science ®Google Scholar
• Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, et al. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery 2012;71:951–961
   PubMed Web of Science ®Google Scholar
• Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, et al. Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 2007;110:471–476
   PubMed Web of Science ®Google Scholar
• Vadivelu S, Sharer L, Schulder M. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg 2010;112:920–924
   PubMed Web of Science ®Google Scholar
• Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997;86:113–120
   PubMed Web of Science ®Google Scholar
• Pravdenkova S, Al-Mefty O, Sawyer J, Husain M. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 2006;105:163–173
   PubMed Web of Science ®Google Scholar
• Sorensen TL, Frederiksen JL, Bronnum-Hansen H, Petersen HC. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 1999;53:473–478
   PubMed Web of Science ®Google Scholar
• Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005;4:111–121
   PubMed Web of Science ®Google Scholar
• Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–532
   PubMed Web of Science ®Google Scholar
• Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129–135
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581–588
   PubMed Web of Science ®Google Scholar
• Optic Neuritis Study G. Mult Scler risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008;65:727–732
   Google Scholar
• Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998;339:285–291
   PubMed Web of Science ®Google Scholar
• Ponsonby AL, Lucas RM, van der Mei IA, Dear K, Valery PC, Pender MP, et al. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 2012;78:867–874
   PubMed Web of Science ®Google Scholar
• Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clin Immunol 2013;149:201--210
   Google Scholar
• Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 2009;175:239–251
   PubMed Web of Science ®Google Scholar
• Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, et al. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010;133:2999–3016
   Google Scholar
• Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002;52:421–428
   PubMed Web of Science ®Google Scholar
• Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004;146:144–152
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE, et al. Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 2007;64:683–688
   PubMed Web of Science ®Google Scholar
• Sadovnick AD. European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. J Neurol Sci 2009;286:1–5
   PubMed Web of Science ®Google Scholar
• Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986;315:1638–1642
   PubMed Web of Science ®Google Scholar
• Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11–15
   PubMed Web of Science ®Google Scholar
• Hansen T, Skytthe A, Stenager E, Petersen HC, Bronnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 2005;11:504–510
   PubMedGoogle Scholar
• Okuda Y, Okuda M, Bernard CC. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol Lett 2002;81:25–29
   PubMed Web of Science ®Google Scholar
• Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996;39:724–733
   Google Scholar
• Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932–6
   PubMed Web of Science ®Google Scholar
• Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr., Lepore V, et al. Geographical variations in sex ratio trends over time in multiple sclerosis. PloS one 2012;7:e48078
   PubMed Web of Science ®Google Scholar
• Palacios N, Alonso A, Bronnum-Hansen H, Ascherio A. Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence. Ann Epidemiol 2011;21:536–42
   PubMed Web of Science ®Google Scholar
• Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother 2013;13:3–9
   PubMed Web of Science ®Google Scholar
• Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, Willoughby E, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010;16:1422–1431
   PubMed Web of Science ®Google Scholar
• Simpson S Jr., Pittas F, van der Mei I, Blizzard L, Ponsonby AL, Taylor B. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry 2011;82:180–187
   Google Scholar
• Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C, et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009;15:9–15
   PubMed Web of Science ®Google Scholar
• Correale J, Ysrraelit MC, Gaitan MI. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 2010;185:4948–4958
   PubMed Web of Science ®Google Scholar
• Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O. The increasing incidence and prevalence of female multiple sclerosis – a critical analysis of potential environmental factors. Autoimmun Rev 2011;10:495–502
   PubMed Web of Science ®Google Scholar
• Koch M, Kingwell E, Rieckmann P, Tremlett H, Neurologists UMC. The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2010;81:1039–1043
   PubMed Web of Science ®Google Scholar
• Khaleeli Z, Ciccarelli O, Manfredonia F, Barkhof F, Brochet B, Cercignani M, et al. Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol 2008;63:790–793
   PubMed Web of Science ®Google Scholar
• Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009;14:4477–515
   PubMed Web of Science ®Google Scholar
• Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, et al. Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler 2012;18:164–173
   Google Scholar
• Costello F, Hodge W, Pan YI, Burton JM, Freedman MS, Stys PK, et al. Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis. Neurology 2012;79:1866–1872
   Google Scholar
• Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–815
   PubMed Web of Science ®Google Scholar
• Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012;9:1--17
   Google Scholar
• Collongues N, de Seze J. Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord 2011;4:111–121
   PubMedGoogle Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–1489
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106–2112
   PubMed Web of Science ®Google Scholar
• Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin 2005;23:17–38
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM. Neuromyelitis optica: effect of gender. J Neurol Sci 2009;286:18–23
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60:848–853
   PubMed Web of Science ®Google Scholar
• Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039–e1047
   PubMed Web of Science ®Google Scholar
• Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344–352
   Google Scholar
• McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93–100
   PubMed Web of Science ®Google Scholar
• Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002;58:885–894
   PubMed Web of Science ®Google Scholar
• Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors, and co-morbidities. Neurology 2001;56:S4–S12
   Google Scholar
• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24:9–160
   PubMed Web of Science ®Google Scholar
• Kurth T, Chabriat H, Bousser MG. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012;11:92–100
   PubMed Web of Science ®Google Scholar
• Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996;119:355–361
   PubMed Web of Science ®Google Scholar
• Cutrer FM, Huerter K. Migraine aura. Neurologist 2007;13:118–125
   Google Scholar
• Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–349
   PubMed Web of Science ®Google Scholar
• Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994;309:765–769
   PubMed Web of Science ®Google Scholar
• Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am Journal epidemiol 1991;134:1111–1120
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;451:S3–S13
   Google Scholar
• Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64–69
   PubMed Web of Science ®Google Scholar
• Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992;12:221–228 (discussion 186)
   PubMed Web of Science ®Google Scholar
• Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991;37:11–23
   PubMed Web of Science ®Google Scholar
• Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996;16:239–245
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004;3:354–361
   PubMed Web of Science ®Google Scholar
• Gupta S, Mehrotra S, Villalon CM, Perusquia M, Saxena PR, MaassenVanDenBrink A. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther 2007;113:321–340
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154–2158
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004;63:351–353
   PubMed Web of Science ®Google Scholar
• Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997;17:765–769
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006;67:2159–2163
   PubMed Web of Science ®Google Scholar
• de Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986;293:1540
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988;2:113–120
   PubMed Web of Science ®Google Scholar
• Nagel-Leiby S, Welch KM, Grunfeld S, D'Andrea G. Ovarian steroid levels in migraine with and without aura. Cephalalgia 1990;10:147–152
   PubMedGoogle Scholar
• Bickerstaff ER. Neurological complications of oral contraceptives. Oxford: Clarendon Press; 1975
   Google Scholar
• Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20:701–707
   PubMed Web of Science ®Google Scholar
• MacGregor A. Estrogen replacement and migraine aura. Headache 1999;39:674–678
   PubMedGoogle Scholar
• Kaiser HJ, Meienberg O. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J Neurol 1993;240:195–196
   PubMed Web of Science ®Google Scholar
• Wright GD, Patel MK. Focal migraine and pregnancy. BMJ 1986;293:1557–1558
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Wroe SJ, Cull RE. Migraine occurring for the first time in pregnancy. Headache 1990;30:224–227
   Google Scholar
• Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995;15:140–144
   PubMed Web of Science ®Google Scholar
• Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Laronningen S, et al. Incidence and outcome of male breast cancer: an International Population-Based Study. J Clin Oncol 2011;29:4381–4386
   PubMed Web of Science ®Google Scholar
• Ahmad SM, Esmaeli B. Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol 2007;18:405–413
   PubMed Web of Science ®Google Scholar
• Wickremasinghe S, Dansingani KK, Tranos P, Liyanage S, Jones A, Davey C. Ocular presentations of breast cancer. Acta Ophthalmol Scand 2007;85:133–142
   Google Scholar
• Shields JaS, CL. Metastatic tumours to the intraocular structures. Intraocular tumours. Philadelphia: Saunder; 1992
   Google Scholar
• Shields JA, Shields CL, Singh AD. Metastatic neoplasms in the optic disc: the 1999 Bjerrum Lecture: part 2. Arch Ophthalmol 2000;118:217–224
   PubMedGoogle Scholar
• Bullock JD, Yanes B. Ophthalmic manifestations of metastatic breast cancer. Ophthalmology 1980;87:961–973
   PubMed Web of Science ®Google Scholar
• Gorin MB, Day R, Costantino JP, Fisher B, Redmond CK, Wickerham L, et al. Long-term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 1998;125:493–501
   PubMed Web of Science ®Google Scholar
• Eisner A, Toomey MD, Falardeau J, Samples JR, Vetto JT. Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors. Breast Cancer Res Treat 2007;106:161–170
   PubMed Web of Science ®Google Scholar
• Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A. Ocular toxicity in low-dose tamoxifen: a prospective study. Eye (Lond) 1999;13:729–733
   PubMed Web of Science ®Google Scholar
• Colley SM, Elston JS. Tamoxifen optic neuropathy. Clin Experiment Ophthalmol 2004;32:105–106
   PubMed Web of Science ®Google Scholar
• Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res 2011;36:867–885
   PubMed Web of Science ®Google Scholar
• Pugesgaard T, Von Eyben FE. Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 1986;58:383–386
   PubMed Web of Science ®Google Scholar
• Levin LA, Adler FH, Kaufman PL, Alm A. Adler’s physiology of the eye. 11th ed. Edingburg: Saunders/Elsevier; 2011
   Google Scholar
• Thompson HS. Adie's syndrome: some new observations. T Am Ophthal Soc 1977;75:587–626
   PubMedGoogle Scholar
• Whitacre CC. Sex differences in autoimmune disease. Nat. Immunol 2001;2:777–780
   PubMed Web of Science ®Google Scholar
• Sharma OP. Sarcoidosis around the world. Clin Chest Med 2008;29:357–363, vii
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr., Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885–1889
   PubMed Web of Science ®Google Scholar
• Phillips YL, Eggenberger ER. Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol 2010;21:423–429
   Google Scholar
• Koczman JJ, Rouleau J, Gaunt M, Kardon RH, Wall M, Lee AG. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol 2008;23:157–68
   PubMedGoogle Scholar
• Fraunfelder FW, Fraunfelder FT. Bisphosphonates and ocular inflammation. N Engl J Med 2003;348:1187–1188
   PubMed Web of Science ®Google Scholar
• Kaur H, Uy C, Kelly J, Moses AM. Orbital inflammatory disease in a patient treated with zoledronate. Endocrine Pract 2011;17:e101–103
   PubMedGoogle Scholar
• Rahimy E, Law SK. Orbital inflammation after zoledronate infusion: an emerging complication. Can J Ophthalmol 2013;48:e11–e12
   Google Scholar
• Missotten G, Verheezen Y. Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma. Bull Soc Belge 2010;315:23–24
   Google Scholar
• Yang EB, Birkholz ES, Lee AG. Another case of bisphosphonate-induced orbital inflammation. J Neuro-ophthalmol 2010;30:94–95
   PubMed Web of Science ®Google Scholar
• Procianoy F, Procianoy E. Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis. Osteoporis Int 2010;21:1057–1058
   PubMed Web of Science ®Google Scholar
• Sharma NS, Ooi JL, Masselos K, Hooper MJ, Francis IC. Zoledronic acid infusion and orbital inflammatory disease. N Engl J Med 2008;359:1410–1411
   PubMed Web of Science ®Google Scholar
• Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology 2001;40:956–957
   PubMed Web of Science ®Google Scholar
• Seth A, Anderson DP, Albiani DA, Barton JJ. Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer. Can J Ophthalmol 2009;44:467–468
   PubMed Web of Science ®Google Scholar
• Phillips PM, Newman SA. Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma. Arch Ophthalmol 2008;126:137–139
   PubMed Web of Science ®Google Scholar
• Subramanian PS, Kerrison JB, Calvert PC, Miller NR. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol 2003;121:1335–1336
   PubMed Web of Science ®Google Scholar
• Mbekeani JN, Slamovits TL, Schwartz BH, Sauer HL. Ocular inflammation associated with alendronate therapy. Arch Ophthalmol 1999;117:837–838
   PubMed Web of Science ®Google Scholar
• Yeo J, Jafer AK. Zolendronate associated inflammatory orbital disease. N Z Med J 2010;123:50–52
   PubMedGoogle Scholar
• Peterson JD, Bedrossian EH, Jr. Bisphosphonate-associated orbital inflammation – a case report and review. Orbit 2012;31:119–123
   PubMedGoogle Scholar
• Smith MR. Diagnosis and management of treatment–related osteoporosis in men with prostate carcinoma. Cancer 2003;97:789–795
   Google Scholar
• Hadji P, Body JJ, Aapro MS, Brufsky A, Coleman RE, Guise T, et al. Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol 2008;19:1407–1416
   PubMed Web of Science ®Google Scholar
• Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008;83:1032–1045
   PubMed Web of Science ®Google Scholar
• Leung S, Ashar BH, Miller RG. Bisphosphonate-associated scleritis: a case report and review. South Med J 2005;98:733–5
   PubMed Web of Science ®Google Scholar
• Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol 2003;135:219–222
   PubMed Web of Science ®Google Scholar
• Edlow JA, Caplan LR, O'Brien K, Tibbles CD. Diagnosis of acute neurological emergencies in pregnant and post-partum women. Lancet Neurol 2013;12:175–185
   PubMed Web of Science ®Google Scholar
• Digre KB. Neuro-ophthalmology and pregnancy: what does a neuro–ophthalmologist need to know? J Neuro-ophthalmol 2011;31:381–387
   Google Scholar
• Digre KB. Headaches during pregnancy. Clin Obstet Gynaecol 2013;56:317–329
   Google Scholar
• Wiebers DO. Ischemic cerebrovascular complications of pregnancy. Arch Neurol 1985;42:1106–1113
   PubMedGoogle Scholar
• Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768–774
   PubMed Web of Science ®Google Scholar
• Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000;31:2948–2951
   PubMed Web of Science ®Google Scholar
• Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol 2009;9:256–267
   PubMedGoogle Scholar
• Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol 2008;19:479–484
   PubMed Web of Science ®Google Scholar
• Digre KB, Varner MW, Osborn AG, Crawford S. Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch Neurol 1993;50:399–406
   PubMedGoogle Scholar
• Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: is there a difference between pregnant and non-pregnant patients? Eur Neurol 2009;62:142–148
   PubMed Web of Science ®Google Scholar
• Chen MM, Coakley FV, Kaimal A, Laros RK, Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 2008;112:333–340
   PubMed Web of Science ®Google Scholar
• Practice ACoO. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004;104:647–651
   Google Scholar
• Yen MY, Wang AG, Wei YH. Leber’s hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res 2006;25:381–396
   PubMed Web of Science ®Google Scholar
• Smith JL, Hoyt WF, Susac JO. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol 1973;90:349–354
   PubMed Web of Science ®Google Scholar
• Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118:319–337
   PubMed Web of Science ®Google Scholar
• Mackey DA, Oostra RJ, Rosenberg T, Nikoskelainen E, Bronte-Stewart J, Poulton J, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:481–485
   PubMed Web of Science ®Google Scholar
• Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros PA, Sadun F, et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003;136:231–238
   PubMed Web of Science ®Google Scholar
• Vansenus AH. Leber's Disease in the Netherlands. Doc Ophthalmol 1963;17:1–162
   Google Scholar
• Seedorff T. The inheritance of Leber's disease. A genealogical follow-up study. Acta Ophthalmol (Copenh) 1985;63:135–145
   PubMed Web of Science ®Google Scholar
• Sadun AA, La Morgia C, Carelli V. Leber's hereditary optic neuropathy. Curr Treat Options Neurol 2011;13:109–117
   PubMed Web of Science ®Google Scholar
• Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet 2002;39:162–169
   PubMed Web of Science ®Google Scholar
• Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros P, Sadun F, et al. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc 2002;100:169–178 (discussion 78–79)
   PubMedGoogle Scholar
• Shankar SP, Fingert JH, Carelli V, Valentino ML, King TM, Daiger SP, et al. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet 2008;29:17–24
   PubMed Web of Science ®Google Scholar
• Hudson G, Keers S, Yu Wai Man P, Griffiths P, Huoponen K, Savontaus ML, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 2005;77:1086–1091
   PubMed Web of Science ®Google Scholar
• Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009;132:2317–2326
   PubMed Web of Science ®Google Scholar